Johnson & Johnson (JNJ) Q1 2025 Earnings Call Highlights: Strong Sales Growth Amid STELARA ...

featured-image

Johnson & Johnson (JNJ) reports robust operational sales growth and a 63rd consecutive dividend increase, despite challenges from STELARA's loss of exclusivity and tariff impacts.

Johnson & Johnson (JNJ) reports robust operational sales growth and a 63rd consecutive dividend increase, despite challenges from STELARA's loss of exclusivity and tariff impacts..